Colorcon Inc., a world leader in the development, supply and technical support of specialty excipients: formulated film coating systems, modified release technologies, and functional excipients for the pharma industry, announced its investment in a new film coating manufacturing plant in Indaiatuba – São Paulo State, Brazil, supporting the continued growth of the pharmaceutical industry in South America.

The construction is scheduled for completion by October 2016 with the production of commercial scale product scheduled for January 2017. Strategically located, the site will produce GMP film coating products for the pharmaceutical and nutritional markets in South America, including Argentina, Brazil, Chile, Paraguay and Uruguay.

Martti Hedman, CEO, Colorcon Inc. explains the significance of Colorcon’s investment as another example of our strategy to position manufacturing facilities close to our customers. “We want to make it easy for customers to work with Colorcon. This facility allows our customers to take advantage of shorter lead times on all of our film coating products, and reduces the risk of importation delays. In addition, the Indaiatuba facility is another important step in further securing the supply chain for our customers, by providing a South American component in Colorcon’ s Business Continuity Plan, with the capability to supply and export film coatings with the same quality, consistency and equivalency for product manufactured in our other six production plants around the world.”

Perry Cozzone, president – Americas adds, “Colorcon is committed to providing the highest quality products and superior service to meet our customer's needs around the world. This investment reinforces our dedication to providing exceptional support we believe our customers deserve while providing greater flexibility in the scheduling of their production, ultimately leading to their products reaching the market faster.”

Colorcon Brazil will continue to support customers across the region with formulation and development of pharmaceutical products through the Technical Service Laboratory already established at Cotia, Sao Paulo. Originally opened in 2000, this support facility has continued to provide samples and applications support for over 16 years in the region.